Why the role of mHealth in allergy diagnosis and treatment adherence cannot be overlooked

IF 4.6 2区医学 Q2 ALLERGY

Clinical and Translational Allergy Pub Date : 2023-10-17 DOI:10.1002/clt2.12298

Anna Szylling, Filip Raciborski, Oksana Wojas, Konrad Furmańczyk, Edyta Krzych-Fałta, Jean Bousquet, Boleslaw Samoliński

{"title":"Why the role of mHealth in allergy diagnosis and treatment adherence cannot be overlooked","authors":"Anna Szylling, Filip Raciborski, Oksana Wojas, Konrad Furmańczyk, Edyta Krzych-Fałta, Jean Bousquet, Boleslaw Samoliński","doi":"10.1002/clt2.12298","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Allergic diseases—rhinitis and asthma—are the most common chronic conditions affecting adults. Traditional approaches to allergy diagnosis and treatment do not meet the health needs of all patients. Treatment adherence remains a challenge for physicians. The ubiquity of Internet access paired with limited in-person contact with medical personnel in the course of the COVID-19 pandemic demonstrated the potential of mHealth in communicating health information.</p>\n </section>\n \n <section>\n \n <h3> Body</h3>\n \n <p>The abundance of new applications dedicated to various medical specialties encourages reflection on the informed use of such tools. The paper takes a closer look at the potential of mHealth and presents conclusions of selected studies focusing on the use of good apps. The strength weakness opportunities threats analysis was used to illustrate the strengths of the mHealth strategy, as well as its advantages, limitations and areas in need of further development.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The strength of mHealth depends on the quality and quantity of the collected patient data, its reliable processing, as well as publication of outcomes and conclusions from analyses. Therefore, it is necessary to promote the use of validated applications among patients, physicians and medical staff.</p>\n </section>\n </div>","PeriodicalId":10334,"journal":{"name":"Clinical and Translational Allergy","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clt2.12298","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Allergy","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clt2.12298","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Allergic diseases—rhinitis and asthma—are the most common chronic conditions affecting adults. Traditional approaches to allergy diagnosis and treatment do not meet the health needs of all patients. Treatment adherence remains a challenge for physicians. The ubiquity of Internet access paired with limited in-person contact with medical personnel in the course of the COVID-19 pandemic demonstrated the potential of mHealth in communicating health information.

Body

The abundance of new applications dedicated to various medical specialties encourages reflection on the informed use of such tools. The paper takes a closer look at the potential of mHealth and presents conclusions of selected studies focusing on the use of good apps. The strength weakness opportunities threats analysis was used to illustrate the strengths of the mHealth strategy, as well as its advantages, limitations and areas in need of further development.

Conclusion

The strength of mHealth depends on the quality and quantity of the collected patient data, its reliable processing, as well as publication of outcomes and conclusions from analyses. Therefore, it is necessary to promote the use of validated applications among patients, physicians and medical staff.

Abstract Image

查看原文本刊更多论文

为什么mHealth在过敏诊断和治疗依从性中的作用不容忽视

背景过敏性疾病——鼻炎和哮喘——是影响成年人的最常见的慢性疾病。传统的过敏诊断和治疗方法不能满足所有患者的健康需求。坚持治疗对医生来说仍然是一个挑战。在新冠肺炎大流行期间，互联网接入的普遍性以及住院人员与医务人员的有限接触表明了mHealth在传播健康信息方面的潜力。身体专门用于各种医学专业的大量新应用程序鼓励人们反思如何在知情的情况下使用这些工具。这篇论文更深入地研究了mHealth的潜力，并提出了一些研究的结论，这些研究侧重于使用好的应用程序。优势-劣势-机会-威胁分析用于说明mHealth战略的优势、优势、局限性和需要进一步发展的领域。结论mHealth的实力取决于收集的患者数据的质量和数量、其可靠的处理以及分析结果和结论的公布。因此，有必要在患者、医生和医务人员中推广使用经过验证的应用程序。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Translational Allergy Immunology and Microbiology-Immunology

CiteScore

7.50

自引率

4.50%

发文量

117

审稿时长

12 weeks

期刊介绍： Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience. Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease.